Skip to content

Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial

Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05180331
Enrollment
10
Registered
2022-01-06
Start date
2023-12-14
Completion date
2024-05-20
Last updated
2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicidal Ideation, Suicide, Suicide and Self-harm, Suicide, Attempted

Brief summary

The primary aim of this grant is to conduct pilot testing on a novel personalized mobile intervention for suicide - Mobile Application to Prevent Suicide (MAPS) - and to establish feasibility, acceptability, safety, and primary outcomes (i.e., suicidal ideation and behavior; re-hospitalization).

Interventions

Safety Planning Intervention, ecological momentary intervention smartphone app system, and bidirectional communication with study clinician.

Sponsors

American Foundation for Suicide Prevention (AFSP)
CollaboratorUNKNOWN
Butler Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 26 Years
Healthy volunteers
No

Inclusion criteria

* Suicidal ideation and/or suicidal behavior in the past month verified by the C-SSRS * Between the ages of 18 and 26 * English proficiency * Comfortable with smartphone technology * Deemed by the treatment team to be stable enough to complete study procedures

Exclusion criteria

* Current psychotic or manic symptoms severe enough to interfere with study procedures

Design outcomes

Primary

MeasureTime frameDescription
Ecological Momentary Assessment (EMA) Adherence4 weeksNumber of assessments completed out of total.
Acceptability of MAPS Intervention1 monthFeedback on qualitative interview.
Satisfaction with MAPS Intervention4 weeksMeasured by protocol completion rate.
Acceptability of Research (Recruitment)BaselineMeasured by recruitment rate.
Acceptability of Research (Dropout)1 monthMeasured by dropout rate.
Acceptability of Research Procedures1 monthFeedback on qualitative interview
Patient Satisfaction1 monthMeasured using the Client Satisfaction Questionnaire, a self-report measure of satisfaction with treatment. Scores range from 8 to 32, with higher scores representing higher satisfaction.

Secondary

MeasureTime frameDescription
Rehospitalization1 monthWill be assessed using the Treatment History Interview and medical records review.
Suicidal Ideation and Behavior1 monthWill be assessed using the Columbia Suicide Severity Rating Scale, items from the Modified Scale for Suicidal Ideation, and ecological momentary assessment of suicidal ideation and behavior. The Columbia Suicide Severity Rating Scale can provide presence/absence of suicidal ideation and suicidal behavior, as well as a suicidal ideation score ranging from 0 to 5 with higher scores representing more severe ideation, and a suicidal ideation intensity rating from 0-25 with higher scores representing more intense ideation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026